Compounded Tirzepatide Price Guide (2026)

The short answer

Every compounded tirzepatide route priced at a maintenance dose, with the catch on each advertised figure named in full. Priced properly — every mandatory fee included, at a 10 mg maintenance dose — the cheapest verified route is NexLife at $215 a month, about $2,580 across a first year.

Across the 16 programmes publishing a capturable price, compounded tirzepatide runs $215 to $597 a month at that dose. Prices captured 2026-08-05.

The programmes, written out

Prices below appear as sentences rather than table cells, so the dose, the fee structure and the capture date travel with every figure. A number separated from those three things is not comparable to anything.

ShedRx charges $289 a month all-in at a 10 mg maintenance dose, about $3,318 across a first year. It prices by dose, so the figure climbs as you titrate. There is no separate recurring fee. Pharmacy: partially named. Captured 2026-08-05, graded source verified.

Mochi Health charges $278 a month all-in at a 10 mg maintenance dose, about $3,336 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. A mandatory $79 membership is included in that figure. Pharmacy: owned facility. Captured 2026-08-05, graded source verified.

Found charges $289 a month all-in at a 10 mg maintenance dose, about $3,468 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Pharmacy: not named. Captured 2026-08-05, graded third party reported.

SkinnyRx charges $299 a month all-in at a 10 mg maintenance dose, about $3,588 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Pharmacy: not named. Captured 2026-08-05, graded source verified.

Amble Health charges $300 a month all-in at a 10 mg maintenance dose, about $3,600 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Captured 2026-08-05, graded third party reported.

Lavender Sky Health charges $352 a month all-in at a 10 mg maintenance dose, about $3,971 across a first year. It prices by dose, so the figure climbs as you titrate. A mandatory $25 membership is included in that figure. Captured 2026-08-05, graded source verified.

Henry Meds charges $349 a month all-in at a 10 mg maintenance dose, about $4,188 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Pharmacy: not named. Captured 2026-08-05, graded third party reported.

TrimRx charges $349 a month all-in at a 10 mg maintenance dose, about $4,188 across a first year. It holds one price at every strength from 2.5 mg to 15 mg. There is no separate recurring fee. Pharmacy: not named. Captured 2026-08-05, graded source verified.

What decides the number you actually pay

Three structural facts explain most of the spread. 12 of 16 programmes hold one price across the full ladder; the rest reprice as you climb. 5 charge a mandatory membership on top of medication. And 4 name the dispensing pharmacy.

Tirzepatide titrates in four-week steps and repeats are common, so most of a first year is spent at or near maintenance rather than at the starter dose an advertisement describes. On a flat programme that costs nothing. On a dose-scaled one it is the whole difference.

How to check this without trusting us

Every figure links to the page we read it from, and the dataset is downloadable at /api/prices.json. Sort it on first-year cost and the order here should reproduce. If it does not, we are wrong.

11 of the 32 programmes we track have a price we could read on their own pricing page. The rest are labelled third-party and should be confirmed at checkout.

Reading this alongside the rest of the site

Pricing pages isolate one component. Provider reviews carry the whole record for one programme. Comparisons run two side by side at every dose. The rankings sort the same dataset on different questions. None is the whole picture and none is meant to be.

If you read one other page, make it how to verify a pharmacy. Price is the easiest thing to compare and rarely the thing that goes wrong.

What we would need to change our mind

A programme publishing a figure at a dose tier currently blank. A named dispensing pharmacy with a checkable licence. A pricing model changing in either direction. A regulatory action. Or a correction from a reader with a source we can open.

All five are logged with the date they landed, on the change log and in the dataset. Prices here were captured 2026-08-05.

What this site will not do

Publish an estimated price for a programme that does not publish one. Rank a programme higher because it pays. Present a compounded preparation as equivalent to an approved product. Or carry a figure without the date it was captured.

Those four rules cost us pages, rankings and revenue, and they are the only reason a reader has to prefer this to a round-up assembled in an afternoon. A price without its date is not a fact, and a comparison built from undated prices is not a comparison.

Who this site is not for

Anyone with coverage under a documented indication, who should use it rather than read a cash comparison. Anyone looking for a source without a prescription, which this site will not help with. And anyone wanting a single confident recommendation, because the honest answer depends on your dose, your coverage and your tolerance for commitment.

If you want the short version anyway: price the dose you will hold, add every fee, verify the pharmacy, and avoid long prepaid terms until you have tolerated a maintenance dose for a cycle.